Q2 2026 Holdings
Filed 2026-08-14 | 84 holdings | $20.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Incyte Corporation(INCY) | COM | 45337C102 | $3.5B | 30,762,330 | 17.5% |
| BeOne Medicines Ltd.(ONC) | SPONSORED ADS | 07725L102 | $2.5B | 8,801,567 | 12.6% |
| Revolution Medicines, Inc.(RVMD) | COM | 76155X100 | $2.1B | 11,443,357 | 10.7% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $1.2B | 2,143,131 | 5.8% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $1.1B | 42,912,904 | 5.4% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $992.7M | 8,657,242 | 5.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $937.8M | 8,796,111 | 4.7% |
| Celcuity Inc.(CELC) | COM | 15102K100 | $828.2M | 7,915,792 | 4.2% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $776.1M | 19,919,186 | 3.9% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $622.3M | 5,604,483 | 3.1% |
| Praxis Precision Medicines, Inc.(PRAX) | COM | 74006W207 | $587.0M | 1,753,198 | 2.9% |
| Alkermes plc(ALKS) | SHS | G01767105 | $524.6M | 10,012,267 | 2.6% |
| Summit Therapeutics Inc.(SMMT) | COM | 86627T108 | $477.7M | 32,786,348 | 2.4% |
| Grail, Inc.(GRAL) | COM | 384747101 | $275.0M | 4,028,614 | 1.4% |
| AbCellera Biologics Inc.(ABCL) | COM | 00288U106 | $259.1M | 33,012,138 | 1.3% |
| Immunovant, Inc.(IMVT) | COM | 45258J102 | $209.4M | 5,435,220 | 1.0% |
| Ideaya Biosciences, Inc.(IDYA) | COM | 45166A102 | $186.7M | 5,010,030 | 0.9% |
| Kiniksa Pharmaceuticals International, plc(KNSA) | ORD SHS CL A | G52694109 | $181.3M | 2,834,643 | 0.9% |
| Roivant Sciences Ltd.(ROIV) | SHS | G76279101 | $166.9M | 4,716,831 | 0.8% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $162.4M | 1,992,783 | 0.8% |
| Ionis Pharmaceuticals, Inc.(IONS) | COM | 462222100 | $162.4M | 2,047,727 | 0.8% |
| Edgewise Therapeutics, Inc.(EWTX) | COM | 28036F105 | $150.4M | 3,701,719 | 0.8% |
| Replimune Group, Inc.(REPL) | COM | 76029N106 | $122.3M | 11,045,336 | 0.6% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $113.0M | 4,658,556 | 0.6% |
| Stoke Therapeutics, Inc.(STOK) | COM | 86150R107 | $109.2M | 3,336,697 | 0.5% |
| Monte Rosa Therapeutics, Inc.(GLUE) | COM | 61225M102 | $105.2M | 4,345,736 | 0.5% |
| Immatics N.V.(IMTX) | SHS | N44445109 | $96.3M | 9,508,565 | 0.5% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $96.0M | 3,734,336 | 0.5% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $88.0M | 2,351,465 | 0.4% |
| Dianthus Therapeutics, Inc.(DNTH) | COM | 252828108 | $83.1M | 852,164 | 0.4% |
| Structure Therapeutics Inc.(GPCR) | SPONSORED ADS | 86366E106 | $76.9M | 1,432,529 | 0.4% |
| Celcuity Inc. | Note 2.75% 8/1/2031 | 15102KAA8 | $69.2M | $30,750,000 | 0.3% |
| Rapport Therapeutics, Inc.(RAPP) | COM | 75383L102 | $64.5M | 1,547,090 | 0.3% |
| Alumis Inc.(ALMS) | COM | 022307102 | $56.6M | 2,012,500 | 0.3% |
| Prelude Therapeutics Inc.(PRLD) | COM | 74065P101 | $54.0M | 10,123,824 | 0.3% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $52.9M | 2,826,783 | 0.3% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $52.2M | 445,975 | 0.3% |
| Bicycle Therapeutics plc(BCYC) | SPONSORED ADS | 088786108 | $46.2M | 10,885,357 | 0.2% |
| Enliven Therapeutics, Inc.(ELVN) | COM | 29337E102 | $45.9M | 905,191 | 0.2% |
| Celldex Therapeutics, Inc.(CLDX) | COM | 15117B202 | $44.0M | 1,182,611 | 0.2% |
| Viridian Therapeutics, Inc.(VRDN) | COM | 92790C104 | $43.8M | 2,383,025 | 0.2% |
| Design Therapeutics, Inc.(DSGN) | COM | 25056L103 | $38.8M | 2,678,430 | 0.2% |
| Entrada Therapeutics, Inc.(TRDA) | COM | 29384C108 | $37.3M | 5,072,730 | 0.2% |
| Faeth Therapeutics, Inc.(SNSE) | COM | 81728A207 | $32.2M | 1,286,411 | 0.2% |
| Aktis Oncology, Inc.(AKTS) | COM | 01021M104 | $32.1M | 996,351 | 0.2% |
| Neurogene Inc.(NGNE) | COM | 64135M105 | $31.2M | 991,691 | 0.2% |
| Jade Biosciences, Inc.(JBIO) | COM | 008064206 | $27.3M | 1,230,426 | 0.1% |
| Taysha Gene Therapies, Inc.(TSHA) | COM SHS | 877619106 | $27.3M | 4,004,756 | 0.1% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $26.0M | 844,816 | 0.1% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $25.6M | 349,657 | 0.1% |